Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD
Clinical trial NCT04521452 · UNKNOWN
Trial details
- NCT number
- NCT04521452
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.